Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mink Therapeutics Inc
(NQ:
INKT
)
0.8390
+0.0291 (+3.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mink Therapeutics Inc
< Previous
1
2
Next >
MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting
March 15, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
March 07, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference
February 16, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference
January 11, 2023
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference
November 17, 2022
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline
November 10, 2022
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results
November 03, 2022
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update
October 20, 2022
Conference Call on Thursday, November 3rd, 2022, at 8:30 a.m. ET
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Host R&D Event November 10, 2022
October 05, 2022
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Selected for Five Presentations at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
October 05, 2022
From
MiNK Therapeutics
Via
GlobeNewswire
MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update
July 27, 2022
Conference Call on Tuesday, August 9th 2022, at 11:00 a.m. ET
From
MiNK Therapeutics
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.